Kinsale Capital Group Inc. has increased its stake in Amgen Inc. (NASDAQ:AMGN), purchasing an additional 4,564 shares of the medical research company's stock during the second quarter.
This brought Kinsale Capital Group Inc.'s total holdings in Amgen to 42,075 shares, accounting for approximately 2% of its overall portfolio.
The value of these shares was $15.24 million as per the company's most recent SEC filing with the SEC.
More on Stocks
Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.
Market sentiment intelligence for apps, funds & agents
Location
729 55 Ave SW
Calgary AB T2V 0G4
Canada
© 2026 Guavy Inc
